The Pediatric Platelet Disorders Program at Weill Cornell Medicine was established four decades ago and is one of the first programs dedicated to children with platelet disorders such as immune thrombocytopenic purpura (ITP), as well as inherited disorders or platelet production or function. Our program pioneered the use of innovative therapies for children using thrombopoietic agents such as romiplastin and eltrombopag.
The Pediatric Oncology Program at Weill Cornell Medicine provides up-to-date comprehensive care to children and adolescents with all forms of childhood cancer. Our specialists have extensive expertise in leukemias, lymphomas and sarcomas of bone and soft tissue. A child life therapist and an art therapist provide invaluable support to children and families getting their treatment in our newly renovated facility.
The Pediatric Thalassemia & Hemoglobinopathy Program at Weill Cornell Medicine follows children with inherited conditions such as thalassemia, sickle cell anemia, spherocytosis, and other red cell disorders, including children with anemia and iron excess/deficiency. We are able to provide transfusions on an outpatient basis, and have state-of-the-art radiology facilities for procedures like MRI for assessing tissue iron.